Consensus of the Brazilian Headache Society on the treatment of chronic migraine

Arquivos de neuro-psiquiatria
Fernando KowacsMauro Eduardo Jurno

Abstract

Chronic migraine poses a significant personal, social and economic burden and is characterized by headache present on 15 or more days per month for at least three months, with at least eight days of migrainous headache per month. It is frequently associated with analgesic or acute migraine medication overuse and this should not be overlooked. The present consensus was elaborated upon by a group of members of the Brazilian Headache Society in order to describe current evidence and to provide recommendations related to chronic migraine pharmacological and nonpharmacological treatment. Withdrawal strategies in medication overuse headache are also described, as well as treatment risks during pregnancy and breastfeeding. Oral topiramate and onabotulinum toxin A injections are the only treatments granted Class A recommendation, while valproate, gabapentin, and tizanidine received Class B recommendation, along with acupuncture, biofeedback, and mindfulness. The anti-CGRP or anti-CGRPr monoclonal antibodies, still unavailable in Brazil, are promising new drugs already approved elsewhere for migraine prophylactic treatment, the efficacy of which in chronic migraine is still to be definitively proven.

References

Mar 20, 1998·Headache·S J Peroutka
Apr 6, 2002·Expert Opinion on Pharmacotherapy·Dawn A Marcus
Jun 5, 2002·Current Opinion in Allergy and Clinical Immunology·Scott H Sicherer
Sep 27, 2003·Cephalalgia : an International Journal of Headache·M SilvestriniL Provinciali
Dec 25, 2003·Neurology·Paul J SpiraUNKNOWN Australian Gabapentin Chronic Daily Headache Group
Mar 17, 2004·BMJ : British Medical Journal·Andrew J VickersRobbert Van Haselen
May 25, 2004·Cephalalgia : an International Journal of Headache·M E BigalR B Lipton
Dec 21, 2004·Cephalalgia : an International Journal of Headache·Z KatsaravaV Limmroth
Dec 20, 2005·The Journal of Headache and Pain·Grazia SancesGiuseppe Nappi
Dec 20, 2005·The Journal of Headache and Pain·Marco TruccoUNKNOWN "Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee" (Neurological Hospital Interregional Group for t
May 6, 2006·Cephalalgia : an International Journal of Headache·G ReljaM Zorzon
May 12, 2006·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification CommitteeT J Steiner
Jul 13, 2006·Neurology·K PaemeleireP J Goadsby
Sep 9, 2006·Clinical Neuropharmacology·Daniele MeiGirolamo Di Trapani
Feb 16, 2007·Headache·Stephen D SilbersteinUNKNOWN Topiramate Chronic Migraine Study Group
Apr 20, 2007·Cephalalgia : an International Journal of Headache·H-C DienerUNKNOWN TOPMAT-MIG-201(TOP-CHROME) Study Group
Aug 8, 2007·Cephalalgia : an International Journal of Headache·N ImaiT Okabe
Aug 30, 2007·Cephalalgia : an International Journal of Headache·I CiancarelliA Carolei
Sep 25, 2007·Cephalalgia : an International Journal of Headache·J Zidverc-TrajkovicN Sternic
Nov 28, 2007·Cephalalgia : an International Journal of Headache·L PagelerV Limmroth
Jan 31, 2008·The Journal of Headache and Pain·Vedat Ali YurekliFatih Gultekin
Mar 8, 2008·Current Treatment Options in Neurology·Jan Lewis Brandes
Jul 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Susanna UsaiGennaro Bussone
Jun 28, 2008·BMJ : British Medical Journal·Peter J GoadsbyStephen D Silberstein
Aug 30, 2008·Cephalalgia : an International Journal of Headache·L P QueirozE Zukerman
Oct 1, 2008·Cephalalgia : an International Journal of Headache·K HagenL J Stovner
Nov 4, 2008·Clinical Neuropharmacology·Pedro Emilio Bermejo, Rodolfo Dorado
Feb 25, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M G BøeA Mygland
Feb 25, 2009·The Journal of Headache and Pain·Marta AllenaUNKNOWN COMOESTAS Consortium
Jul 21, 2009·Cephalalgia : an International Journal of Headache·J L NatoliR B Lipton
Sep 9, 2009·Cephalalgia : an International Journal of Headache·H-C DienerS J Greenberg
Nov 26, 2009·Clinical Neuropharmacology·Elena P CalandreCarmen M Rodriguez-Lopez
Mar 20, 2010·Headache·Marco TruccoUNKNOWN Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee (Neurological Hospital Interregional Group for the
Apr 20, 2010·Clinical Neurology and Neurosurgery·Elza MagalhãesAilton Melo
Jun 10, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R B GrandeM B Russell

❮ Previous
Next ❯

Citations

Jul 24, 2021·Acta neurologica Belgica·Anna Letícia Moraes AlvesPedro Augusto Sampaio Rocha-Filho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Pain and Headache Reports
Hans-Christoph DienerDavid Dodick
American Family Physician
Joseph R YanceyKelly G Koren
Der Nervenarzt
H C DienerK Rabe
© 2021 Meta ULC. All rights reserved